Deregulation of fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes

Human Molecular Genetics

Volumn 23, Issue 5, 2014, Pages 1151-1162

  Oldenburg, Anja R ^a   Delbarre, Erwan ^a   Thiede, Bernd ^b   Vigouroux, Corinne ^c,d,e,f   Collas, Philippe ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e ICAN   (France)

^f HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTES; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL DIFFERENTIATION; CODON; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LAMIN TYPE A; LIPODYSTROPHY; LIPODYSTROPHY, FAMILIAL PARTIAL; MOLECULAR SEQUENCE DATA; MUSCLE DEVELOPMENT; MUTATION; NUCLEAR ENVELOPE; PEPTIDES; PROTEIN BINDING; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA-BINDING PROTEINS; STEM CELLS;

EID: 84894086580     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt509     Document Type: Article

References (73)

1. Burke, B. and Stewart, C.L. (2013) The nuclear lamins: flexibility in function. Nat. Rev. Mol. Cell Biol., 14, 13-24.
2. Gerace, L. and Huber, M.D. (2012) Nuclear lamina at the crossroads of the cytoplasm and nucleus. J. Struct. Biol., 177, 24-31.
3. Schreiber, K.H. and Kennedy, B.K. (2013) When lamins go bad: nuclear structure and disease. Cell, 152, 1365-1375.
4. Kind, J. and van Steensel, B. (2010) Genome-nuclear lamina interactions and gene regulation. Curr. Opin. Cell Biol., 22, 320-325.
5. Mattout, A., Pike, B.L., Towbin, B.D., Bank, E.M., Gonzalez-Sandoval, A., Stadler, M.B., Meister, P., Gruenbaum, Y. and Gasser, S.M. (2011) An EDMDmutation in C. elegans lamin blocks muscle-specific gene relocation and compromises muscle integrity. Curr. Biol., 21, 1603-1614.
6. Ho, C.Y., Jaalouk, D.E., Vartiainen, M.K. and Lammerding, J. (2013) Lamin A/Cand emerin regulateMKL1-SRFactivity by modulating actin dynamics. Nature, 497, 507-511.
7. Worman, H.J. (2012) Nuclear lamins and laminopathies. J. Pathol., 226, 316-325.
8. Dhe-Paganon, S., Werner, E.D., Chi, Y.I. and Shoelson, S.E. (2002) Structure of the globular tail of nuclear lamin. J. Biol. Chem., 277, 17381- 17384.
9. Krimm, I., Ostlund, C., Gilquin, B., Couprie, J., Hossenlopp, P., Mornon, J.P., Bonne, G., Courvalin, J.C., Worman, H.J. and Zinn-Justin, S. (2002) The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure, 10, 811-823.
10. Bonne, G., di Barletta, M.R., Varnous, S., Becane, H.M., Hammouda, E.H., Merlini, L., Muntoni, F., Greenberg, C.R., Gary, F., Urtizberea, J.A. et al. (1999) Mutations in the gene encoding laminA/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet., 21, 285-288.
11. Shackleton, S., Lloyd, D.J., Jackson, S.N., Evans, R., Niermeijer, M.F., Singh, B.M., Schmidt, H., Brabant, G., Kumar, S., Durrington, P.N. et al. (2000) LMNA,encoding lamin A/C, is mutated in partial lipodystrophy. Nat. Genet., 24, 153-156.
12. Vigouroux, C., Magre, J., Vantyghem, M.C., Bourut, C., Lascols, O., Shackleton, S., Lloyd, D.J., Guerci, B., Padova, G., Valensi, P. et al. (2000) Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes, 49, 1958-1962.
13. Bidault, G., Vatier, C., Capeau, J., Vigouroux, C. and Bereziat, V. (2011) LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations. Biochem. Soc. Trans., 39, 1752-1757.
14. Boschmann, M., Engeli, S., Moro, C., Luedtke, A., Adams, F., Gorzelniak, K., Rahn, G., Mahler, A., Dobberstein, K., Kruger, A. et al. (2010) LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J. Clin. Endocrinol. Metab., 95, 1634-1643.
15. Ji, H., Weatherall, P.,Adams-Huet, B. and Garg, A. (2013) Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety. J. Clin. Endocrinol. Metab., 98, E1410-E1413.
16. Spuler, S., Kalbhenn, T., Zabojszcza, J., van Landeghem, F.K., Ludtke, A., Wenzel, K., Koehnlein, M., Schuelke, M., Ludemann, L. and Schmidt, H.H. (2007) Muscle and nerve pathology in Dunnigan familial partial lipodystrophy. Neurology, 68, 677-683.
17. Vantyghem, M.C., Pigny, P., Maurage, C.A., Rouaix-Emery, N., Stojkovic, T., Cuisset, J.M., Millaire, A., Lascols, O., Vermersch, P., Wemeau, J.L. et al. (2004) Patients with familial partial lipodystrophy of the Dunnigantype due to aLMNAR482W mutation show muscular and cardiac abnormalities. J. Clin. Endocrinol. Metab., 89, 5337-5346.
18. Stierle, V., Couprie, J., Ostlund, C., Krimm, I., Zinn-Justin, S., Hossenlopp, P., Worman, H.J., Courvalin, J.C. and Duband-Goulet, I. (2003) The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry, 42, 4819-4828.
19. Duband-Goulet, I., Woerner, S., Gasparini, S., Attanda, W., Konde, E., Tellier-Lebegue, C., Craescu, C.T., Gombault, A., Roussel, P., Vadrot, N. et al. (2011) Subcellular localization of SREBP1 depends on its interaction with the C-terminal region of wild-type and disease related A-type lamins. Exp. Cell Res., 317, 2800-2813.
20. Khandjian, E.W. (1999) Biology of the fragileX mental retardation protein, an RNA-binding protein. Biochem. Cell Biol., 77, 331-342.
21. Jin, P., Alisch, R.S. and Warren, S.T. (2004) RNAand microRNAs in fragile X mental retardation. Nat. Cell Biol., 6, 1048-1053.
22. Vasudevan, S., Tong, Y. and Steitz, J.A. (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931- 1934.
23. Kirkpatrick, L.L., McIlwain, K.A. and Nelson, D.L. (2001) Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. Genomics, 78, 169-177.
24. Mientjes, E.J., Willemsen, R., Kirkpatrick, L.L., Nieuwenhuizen, I.M., Hoogeveen-Westerveld, M., Verweij, M., Reis, S., Bardoni, B., Hoogeveen, A.T., Oostra, B.A. et al. (2004) Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo. Hum. Mol. Genet., 13, 1291-1302.
25. Davidovic, L., Durand, N., Khalfallah, O., Tabet, R., Barbry, P., Mari, B., Sacconi, S., Moine, H. and Bardoni, B. (2013) A novel role for the RNA-binding protein FXR1P in myoblasts cell-cycle progression by modulating p21/Cdkn1a/Cip1/Waf1 mRNA stability. PLoS Genet., 9, e1003367.
26. Huot, M.E., Bisson, N., Davidovic, L., Mazroui, R., Labelle, Y., Moss, T. and Khandjian, E.W. (2005) The RNA-binding protein fragile X-related 1 regulates somite formation in Xenopus laevis. Mol. Biol. Cell, 16, 4350- 4361.
27. van't Padje, S., Chaudhry, B., Severijnen, L.A., van der Linde, H.C., Mientjes, E.J., Oostra, B.A. and Willemsen, R. (2009) Reduction in fragileX related 1 protein causes cardiomyopathy and muscular dystrophy in zebrafish. J. Exp. Biol., 212, 2564-2570.
28. Davidovic, L., Sacconi, S., Bechara, E.G., Delplace, S., Allegra, M., Desnuelle, C. and Bardoni, B. (2008) Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients. J. Med. Genet., 45, 679- 685.
29. Tassone, F., Iwahashi, C. and Hagerman, P.J. (2004) FMR1RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol., 1, 103-105.
30. Iwahashi, C.K., Yasui, D.H., An, H.J., Greco, C.M., Tassone, F., Nannen, K., Babineau, B., Lebrilla, C.B., Hagerman, R.J. and Hagerman, P.J. (2006) Protein composition of the intranuclear inclusions of FXTAS. Brain, 129, 256-271.
31. Arocena, D.G., Iwahashi, C.K., Won, N., Beilina, A., Ludwig, A.L., Tassone, F., Schwartz, P.H. and Hagerman, P.J. (2005) Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum. Mol. Genet., 14, 3661-3671.
32. Ruppelt, A., Mosenden, R., Gronholm, M., Aandahl, E.M., Tobin, D., Carlson, C.R., Abrahamsen, H., Herberg, F.W., Carpen, O. and Tasken, K. (2007) Inhibition ofT cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin. J. Immunol., 179, 5159-5168.
33. Boquest, A.C., Shahdadfar, A., Fronsdal, K., Sigurjonsson, O., Tunheim, S.H., Collas, P. and Brinchmann, J.E. (2005) Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol. Biol. Cell, 16, 1131-1141.
34. Vasudevan, S. and Steitz, J.A. (2007) AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell, 128, 1105- 1118.
35. Cao, H. and Hegele, R.A. (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet., 9, 109-112.
36. Rosen, E.D. and MacDougald, O.A. (2006) Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol., 7, 885-896.
37. Boguslavsky, R.L., Stewart, C.L. and Worman, H.J. (2006) Nuclear laminA inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet., 15, 653-663.
38. Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C.L. and Burke, B. (1999) Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol., 147, 913-920.
39. Maresca, G., Natoli, M., Nardella, M., Arisi, I., Trisciuoglio, D., Desideri, M., Brandi, R., D'Aguanno, S., Nicotra, M.R., D'Onofrio, M. et al. (2012) LMNA knock-down affects differentiation and progression of human neuroblastoma cells. PLoS One, 7, e45513.
40. Scaffidi, P. and Misteli, T. (2008) Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat. Cell Biol., 10, 452-459.
41. Cutler, D.A., Sullivan, T., Marcus-Samuels, B., Stewart, C.L. and Reitman, M.L. (2002) Characterization of adiposity and metabolism in Lmna-deficient mice. Biochem. Biophys. Res. Commun., 291, 522-527.
42. Sørensen, A.L., Timoskainen, S., West, F.D., Vekterud, K., Boquest, A.C., Ahrlund-Richter, L., Stice, S.L. and Collas, P. (2009) Lineage-specific promoter DNA methylation patterns segregate adult progenitor cell types. Stem Cells Dev., 19, 1257-1266.
43. Vigouroux, C. and Bonne, G. (2002) In Collas, P. (ed), Nuclear envelope dynamics in embryos and somatic cells. Landes Biosciences, Georgetown, TX, USA, Vol. 23, pp. 153-172.
44. Hegele, R.A., Anderson, C.M., Wang, J., Jones, D.C. and Cao, H. (2000) Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res., 10, 652-658.
45. Buckingham, M. and Relaix, F. (2007) The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol., 23, 645-673.
46. Caron, M., Auclair, M., Donadille, B., Bereziat, V., Guerci, B., Laville, M., Narbonne, H., Bodemer, C., Lascols, O., Capeau, J. et al. (2007) Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ., 14, 1759-1767.
47. Decaudain, A., Vantyghem, M.C., Guerci, B., Hecart, A.C., Auclair, M., Reznik, Y., Narbonne, H., Ducluzeau, P.H., Donadille, B., Lebbe, C. et al. (2007) New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J. Clin. Endocrinol. Metab., 92, 4835-4844.
48. Favreau, C., Delbarre, E., Courvalin, J.C. and Buendia, B. (2008) Differentiation of C2C12 myoblasts expressing lamin A mutated at a site responsible for Emery-Dreifuss muscular dystrophy is improved by inhibition of the MEK-ERK pathway and stimulation of the PI3-kinase pathway. Exp. Cell Res., 314, 1392-1405.
49. Say, E., Tay, H.G., Zhao, Z.S., Baskaran, Y., Li, R., Lim, L. and Manser, E. (2010) A functional requirement for PAK1 binding to the KH(2) domain of the fragile X protein-related FXR1. Mol. Cell, 38, 236-249.
50. Muchir, A., Kim, Y.J., Reilly, S.A., Wu, W., Choi, J.C. and Worman, H.J. (2013) Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation. Skelet. Muscle, 3, 17-3.
51. Chen, S.C., Kennedy, B.K. and Lampe, P.D. (2013) Phosphorylation of connexin43 on S279/282 may contribute to laminopathy-associated conduction defects. Exp. Cell Res., 319, 888-896.
52. Muchir, A., Wu, W., Choi, J.C., Iwata, S., Morrow, J., Homma, S. and Worman, H.J. (2012) Abnormal p38alpha mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation. Hum. Mol. Genet., 21, 4325-4333.
53. Cheever, A. and Ceman, S. (2009) Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway. RNA Biol., 6, 175-178.
54. Cheever, A., Blackwell, E. and Ceman, S. (2010) Fragile X protein family member FXR1P is regulated by microRNAs. RNA, 16, 1530-1539.
55. Zongaro, S., Hukema, R., D'Antoni, S., Davidovic, L., Barbry, P., Catania, M.V., Willemsen, R., Mari, B. and Bardoni, B. (2013) The 3' UTR of FMR1 mRNA is a target of miR-101, miR-129-5p and miR-221: implications for the molecular pathology of FXTAS at the synapse. Hum. Mol. Genet., 22, 1971-1982.
56. Kubben, N., Adriaens, M., Meuleman, W., Voncken, J.W., van Steensel, B. and Misteli, T. (2012) Mappingof laminA- and progerin-interactinggenome regions. Chromosoma, 121, 447-464.
57. McCord, R., Nazario-Toole, A., Zhang, H., Chines, P., Zhan, Y., Erdos, M., Collins, F., Dekker, J. and Cao, K. (2012) Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome. Genome. Res., 23, 260-269.
58. Sylvius, N., Bonne, G., Straatman, K., Reddy, T., Gant, T.W. and Shackleton, S. (2011) MicroRNA expression profiling in patients with lamin A/C-associated muscular dystrophy. FASEB J., 25, 3966-3978.
59. Chen, H., Chen, X. and Zheng, Y. (2013) The nuclear lamina regulates germline stem cell niche organization via modulation of EGFR signaling. Cell Stem Cell, 13, 73-86.
60. Tamanini, F., Bontekoe, C., Bakker, C.E., van Unen, L., Anar, B., Willemsen, R., Yoshida, M., Galjaard, H., Oostra, B.A. and Hoogeveen, A.T. (1999) Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Hum. Mol. Genet., 8, 863-869.
61. Cook, D., Sanchez-Carbente, M.R., Lachance, C., Radzioch, D., Tremblay, S., Khandjian, E.W., DesGroseillers, L. and Murai, K.K. (2011) Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus. PLoS One, 6, e26120.
62. Ascano, M. Jr., Mukherjee, N., Bandaru, P., Miller, J.B., Nusbaum, J.D., Corcoran, D.L., Langlois, C., Munschauer, M., Dewell, S., Hafner, M. et al. (2012) FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature, 492, 382-386.
63. Verstraeten, V.L., Renes, J., Ramaekers, F.C., Kamps, M., Kuijpers, H.J., Verheyen, F., Wabitsch, M., Steijlen, P.M., van Steensel, M.A. and Broers, J.L. (2011) Reorganization of the nuclear lamina and cytoskeleton in adipogenesis. Histochem. Cell Biol., 135, 251-261.
64. Heessen, S. and Fornerod, M. (2007) The inner nuclear envelope as a transcription factor resting place. EMBO Rep., 8, 914-919.
65. Lloyd, D.J., Trembath, R.C. and Shackleton, S. (2002) A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum. Mol. Genet., 11, 769-777.
66. Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H.F. Jr., Motomura, K., Anania, F.A., Willson, T.M. and Tsukamoto, H. (2000) Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem., 275, 35715-35722.
67. Schneider, E., Schmid-Kotsas, A., Zhao, J., Weidenbach, H., Schmid, R.M., Menke, A., Adler, G., Waltenberger, J., Grunert, A. and Bachem, M.G. (2001) Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am. J. Physiol. Cell Physiol., 281, C532-C543.
68. McGowan, S.E., Jackson, S.K., Doro, M.M. and Olson, P.J. (1997) Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts. Am. J. Physiol., 273, 1249-1257.
69. Jakkaraju, S., Zhe, X., Pan, D., Choudhury, R. and Schuger, L. (2005) TIPs are tension-responsive proteins involved in myogenic versus adipogenic differentiation. Dev. Cell, 9, 39-49.
70. Suzuki, K., Bose, P., Leong-Quong, R.Y., Fujita, D.J. and Riabowol, K. (2010) REAP: a two minute cell fractionation method. BMC Res. Notes, 3, 294-297.
71. Steen, R.L. and Collas, P. (2001) Mistargeting of B-type lamins at the end of mitosis: implications on cell survival and regulation of lamins A/C expression. J. Cell Biol., 153, 621-626.
72. Frank, R. (2002) The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods, 267, 13-26.
73. Koehler, C.J., Strozynski, M., Kozielski, F., Treumann, A. and Thiede, B. (2009) Isobaric peptide termini labeling for MS/MS-based quantitative proteomics. J. Proteome Res., 8, 4333-4341.